Physician profile
Tak W Kwan
NPI 1639130925
$71,834.53
in general payments reported to CMS, 2019-2025
37 companies · $25K in 2025
The $25K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,539 · 2020: $5,201 · 2021: $5,402 · 2022: $6,451 · 2023: $15K · 2024: $7,905 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27K · Consulting Fee: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,600 · Travel and Lodging: $3,464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26,678.26 |
| Consulting Fee | $11,500.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,600.00 |
| Travel and Lodging | $3,463.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spectrawave, INC | $15,594.71 | 2023-2025 | Hypervue Imaging System, Starlight Imaging Catheter |
| Shockwave Medical, INC | $12,056.14 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $9,743.52 | 2024-2025 | Endocross Device, Torus Stent Graft System |
| Boston Scientific Corporation | $7,878.01 | 2019-2025 | Avvigo Guidance System, General - Therapies, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $6,045.74 | 2019-2025 | Diamondback Coronary, Optis, Dragonfly Opstar |
| Cardiovascular Systems INC. | $5,802.82 | 2019-2023 | Diamondback Peripheral |
| Medtronic, INC. | $3,288.50 | 2021-2025 | Onyx Frontier, Symplicity G3, Acist Rxi System |
| Abiomed | $2,466.88 | 2019-2025 | Impella |
| Philips North America LLC | $2,351.77 | 2019-2025 | Coronary Other |
| Janssen Pharmaceuticals, INC | $941.00 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $673.25 | 2020-2025 | Rotarexs 6 F X 135 Cm, Venclose Maven Catheter |
| Acist Medical Systems, INC. | $538.51 | 2024-2025 | |
| Heartflow, INC. | $495.86 | 2023-2025 | Ffrct |
| Esperion Therapeutics, INC. | $436.36 | 2021 | |
| Recor Medical INC | $358.12 | 2025 | Paradise Ultrasound Renal Denervation System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cathworks, INC. | $350.81 | 2023-2025 | Ffrangio |
| Cleerly, INC. | $343.76 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Stryker Corporation | $326.90 | 2025 | Limflow System |
| Arineta, INC | $259.00 | 2024 | Spotlight |
| Cordis US Corp. | $248.41 | 2024-2025 | Selution Slr Ptca, Mynx Control |
| Medtronic Vascular, INC. | $212.60 | 2019 | |
| Astellas Pharma US INC | $204.73 | 2020-2022 | |
| Inari Medical, INC. | $182.04 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biotronik INC. | $134.51 | 2025 | Biomonitor |
| Teleflex LLC | $127.45 | 2025 | Twin-Pass |
| Regeneron Healthcare Solutions, INC. | $127.14 | 2019 | |
| Siemens Medical Solutions USA, INC. | $123.98 | 2019 | |
| Cvrx, INC. | $123.43 | 2021 | |
| Novo Nordisk INC | $109.63 | 2022 | |
| Terumo Medical Corporation | $101.18 | 2025 | Metacross Otw, Heartrail, Glidewire |
| Chiesi USA, INC. | $73.33 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $22.66 | 2020 | |
| Novartis Pharmaceuticals Corporation | $21.04 | 2021 | |
| Surmodics, INC. | $20.67 | 2019 | |
| Verge Medical, INC. | $19.00 | 2019 | |
| Penumbra, INC. | $16.82 | 2020 | |
| Cook Medical LLC | $14.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,503,203.40 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tak Kwan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.